- Home
- IINN vs PASG Comparison
IINN vs PASG Comparison
Compare IINN & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- PASG
- Stock Information
- Founded
- IINN 2018
- PASG 2017
- Country
- IINN Israel
- PASG United States
- Employees
- IINN N/A
- PASG N/A
- Industry
- IINN Medical/Dental Instruments
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- PASG Health Care
- Exchange
- IINN Nasdaq
- PASG Nasdaq
- Market Cap
- IINN 32.4M
- PASG 27.6M
- IPO Year
- IINN 2021
- PASG 2020
- Fundamental
- Price
- IINN $1.03
- PASG $8.93
- Analyst Decision
- IINN Strong Buy
- PASG Strong Buy
- Analyst Count
- IINN 1
- PASG 4
- Target Price
- IINN $2.00
- PASG $34.50
- AVG Volume (30 Days)
- IINN 171.6K
- PASG 41.6K
- Earning Date
- IINN 10-01-2025
- PASG 11-10-2025
- Dividend Yield
- IINN N/A
- PASG N/A
- EPS Growth
- IINN N/A
- PASG N/A
- EPS
- IINN N/A
- PASG N/A
- Revenue
- IINN $289,000.00
- PASG N/A
- Revenue This Year
- IINN N/A
- PASG N/A
- Revenue Next Year
- IINN $2,582.74
- PASG N/A
- P/E Ratio
- IINN N/A
- PASG N/A
- Revenue Growth
- IINN N/A
- PASG N/A
- 52 Week Low
- IINN $0.40
- PASG $5.12
- 52 Week High
- IINN $1.65
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- IINN 54.28
- PASG 55.70
- Support Level
- IINN $0.90
- PASG $7.13
- Resistance Level
- IINN $1.00
- PASG $9.12
- Average True Range (ATR)
- IINN 0.06
- PASG 0.96
- MACD
- IINN 0.02
- PASG 0.09
- Stochastic Oscillator
- IINN 96.77
- PASG 66.71
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.